<DOC>
	<DOC>NCT01902212</DOC>
	<brief_summary>The objective of this study is to capture gastrointestinal tolerance (GI) information on a nutrient dense oral nutritional supplement (ONS) in healthy elderly subjects.</brief_summary>
	<brief_title>Evaluation of an Oral Nutrition Supplement</brief_title>
	<detailed_description />
	<criteria>Subjects will be eligible for the study if they meet all of the following inclusion criteria: Male or female ≥ 60 and ≤ 90 years of age. Body Mass Index (BMI) &gt; 20 but &lt; 35. Subjects will be excluded from the study if they meet any of the following criteria: History of diabetes Antibiotic use within 1 week prior to enrollment Undergone major surgery less than 3 months prior to enrollment. Current active malignant disease or was treated within the last 6 months for cancer. Immunodeficiency disorder. Myocardial infarction within the last 3 months. Chronic obstructive pulmonary disease (COPD). Allergy to any of the ingredients in the study product. Obstruction of the gastrointestinal tract or other major gastrointestinal disease. Dementia, brain metastases, eating disorders, history of significant neurological or psychiatric disorder. Unintentional weight loss or weight gain ≥ 5% in last 4 weeks. Taking medications/dietary supplements/substances that could profoundly modulate metabolism or affect GI motility.</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>